Search

The article discusses the role of androgen stimulation in reorganizing 3D chromatin structure and triggering AR-mediated transcription in prostate cancer. Through a time-course model, researchers found that rapid AR binding at gene promoters drives nascent transcription of AR target genes. The study highlights the temporal relationship between MYC and AR transcriptional regulation in hormone-driven cancers, contributing to a deeper understanding of AR regulation in prostate cancer. This preprint has not been peer-reviewed and provides valuable insights into the epigenomic dynamics of AR-mediated transcription in prostate cancer. [Extracted from the article]

The article discusses the development of EpiAgent, a foundation model for single-cell epigenomic data analysis. EpiAgent is trained on a large-scale dataset and excels in tasks such as feature extraction, cell annotation, and data imputation. It also enables the prediction of cellular responses to genetic perturbations and facilitates cancer analysis through in-silico treatment simulations. The model's zero-shot capabilities allow for direct cell type annotation on new datasets without additional training. [Extracted from the article]

The article discusses the formation of distinct shelterin subcomplexes at telomeres, which protect chromosome ends and regulate telomerase access. The shelterin complex consists of six proteins that can assemble into various subcomplexes. Through live-cell imaging and analysis, it was found that TRF1-TIN2-TPP1-POT1 and TRF2-RAP1 form separate subcomplexes at telomeres, with different binding dynamics. This research provides insight into the essential functions of shelterin proteins in telomere maintenance and advances understanding of telomeric chromatin structure. [Extracted from the article]

The article discusses the development of ChromBPNet, a deep learning model that analyzes chromatin accessibility to identify regulatory sequence syntax, transcription factor footprints, and genetic variants. The model aims to decode the complex regulatory DNA and genetic variation that influence transcription factor binding and chromatin accessibility across different cellular contexts and ancestries. Despite its lightweight design, ChromBPNet shows competitive performance in predicting variant effects on chromatin accessibility and identifying regulatory variants that impact complex traits and rare diseases. This preprint has not yet undergone peer review. [Extracted from the article]

The article discusses a study on the coordination and activity of chromatin-associated proteins (CAPs) in different cell types, specifically K562 and HepG2 cancer cell lines. Through integrative analysis of 270 CAP chromatin immunoprecipitation experiments, the study identified distinct CAP co-association modules in each cell line, revealing cell type-specific regulatory mechanisms. The research highlights the importance of CAP genomic organization in transcriptional regulation and cellular functions, emphasizing the significance of cell identity in chromatin dynamics. This preprint has not yet undergone peer review and can be accessed for further information at biorxiv.org/content/10.1101/2024.12.17.628199v1. [Extracted from the article]

A recent study from Sichuan University in Chengdu, China, focuses on targeting epigenetic dysregulations in head and neck squamous cell carcinoma (HNSCC). The research highlights the importance of exploring alternative therapeutic strategies to address the lack of innovative treatment approaches for HNSCC. By summarizing recent discoveries of epigenetic dysregulations in HNSCC, the study sheds light on potential novel prognostic biomarkers and targeted antitumor therapies. The findings suggest that targeting the epigenetic machinery could offer promising prospects for overcoming resistance to conventional radiotherapy/chemotherapy and enhancing the response to immunotherapy in HNSCC. [Extracted from the article]

A recent study conducted at Jiangsu University in Zhenjiang, People's Republic of China, explored the role of chromatin regulators in influencing the efficacy of immune checkpoint inhibitors (ICIs) in gastric cancer (GC). The study identified CHAF1A as a key gene regulating chromatin that was associated with a favorable response to immunotherapy, independent of classic biomarkers. The research suggests that CHAF1A could serve as a novel biomarker for improving patient selection in immunotherapy. For more information, the study "An Oncogene Regulating Chromatin Favors Response To Immunotherapy" can be accessed through Oncoimmunology. [Extracted from the article]

The article discusses the identification of SMARCA1 as a key regulator for colorectal cancer through a systematic investigation of histone modification recognition proteins in colorectal cancer cell lines. The study found that SMARCA1 was downregulated in metastatic colorectal cancer cells and its high expression was correlated with poor patient prognosis, suggesting its role in promoting colorectal cancer metastasis. The research highlights SMARCA1 as a potential driver of colorectal cancer metastasis and a promising therapeutic target for patients. [Extracted from the article]

The article from Cancer Weekly discusses the role of the chromatin regulator HELLS in single-strand break (SSB) repair and responses to DNA alkylation damage in cancer cells. HELLS has been identified as a key player in cell proliferation, genome stability, and various cancer pathways, with its upregulation observed in multiple human cancer types. The study reveals that loss of HELLS impairs SSB repair and sensitizes cells to DNA alkylating agents and PARP inhibitors, suggesting a potential therapeutic target for cancer treatment. The research highlights the importance of understanding HELLS' function in DNA repair mechanisms and its implications for cancer therapy. [Extracted from the article]

The article discusses the disruption of the epigenetic regulator BAP1, which leads to chromatin remodeling and the emergence of cells with breast cancer stem cell properties and aberrant glycosylation. The study highlights the impact of BAP1 loss on cellular processes like epithelial-to-mesenchymal transition and glycan abundance. The research suggests that BAP1 plays a crucial role in regulating cell identity and glycosylation in mammary cells, indicating its significance in breast cancer development. [Extracted from the article]

The article discusses a new method called targeted deaminase-accessible chromatin sequencing (TDAC-seq) that combines CRISPR scanning with chromatin accessibility profiling to study gene regulation and develop gene therapies. By using a double-stranded DNA deaminase, researchers can analyze chromatin accessibility at specific loci with high depth and resolution, allowing for the functional dissection of cis-regulatory elements. The study demonstrates the application of TDAC-seq in activating fetal hemoglobin in human hematopoietic stem cells and in screening enhancers controlling the globin locus. This innovative approach enables high-resolution mapping of chromatin fibers through genome editing techniques. [Extracted from the article]

The article discusses the role of chromatin fragments in chronic inflammation and aging, highlighting the connection between inflammation and metabolism. It explains how chromatin fragments exit the nucleus through nuclear egress, a process inhibited by metformin treatment. The study suggests that targeting the nuclear egress of chromatin fragments could be a new approach to suppress age-associated inflammation. [Extracted from the article]

The article discusses the potential benefits of using the CoREST complex inhibitor, corin, in treating atypical teratoid rhabdoid tumors (ATRT). The study found that corin inhibited tumor growth, increased cellular differentiation, and extended lifespan in ATRT xenograft models. The results suggest that CoREST complex inhibitors like corin could be a promising treatment option for patients with ATRT, as they suppress tumor growth and promote apoptosis. [Extracted from the article]

A recent study by Boehringer Ingelheim Pharma GmbH & Co. KG in Biberach, Germany, explores the molecular mechanisms behind idiopathic pulmonary fibrosis (IPF) progression. The research highlights the role of metabolic alteration, chromatin accessibility, and transcriptional regulation in aberrant epithelial remodeling in IPF. The findings suggest a novel link between metabolic dysregulation and cell fate regulation at the chromatin level, offering potential avenues for new therapeutic strategies in IPF. [Extracted from the article]

The article discusses a study on the genetic regulation of human skeletal muscle, focusing on identifying cell types, regulatory elements, target genes, and causal variants related to metabolic traits and diseases like type 2 diabetes. Through population-scale single nucleus chromatin accessibility and transcriptome mapping, the researchers identified cell types, expression quantitative trait loci (eQTL), chromatin accessibility QTLs (caQTL), and genetic regulatory patterns across different cell types. The study sheds light on the genetic regulatory architecture of human skeletal muscle and provides insights into population-scale multi-omic mapping in complex tissues and traits. [Extracted from the article]

The article discusses the development of a deep generative model called mmVelo, which aims to estimate cell state-dependent dynamics across multiple modalities in single-cell multiomics data. By analyzing spliced and unspliced mRNA expression, mmVelo projects dynamics onto chromatin accessibility, enhancing our understanding of regulatory relationships across molecular layers. The model was applied to data from a developing mouse brain and validated for accuracy, identifying crucial transcription factors for chromatin accessibility regulation in mouse skin. Additionally, the study demonstrates the ability to infer missing modalities during human brain development through cross-modal generation. [Extracted from the article]

The article discusses the development of a framework called HALO, which uses a causal approach to model temporal relationships between chromatin accessibility and gene expression in single-cell multi-omics data. HALO identifies dynamic interactions between these modalities on both a representation level and an individual gene level, revealing insights into cellular states and dynamics. The framework has shown promise in uncovering biological functions, epigenetic factors for lineage specification, and temporal cis-regulation interactions relevant to cellular differentiation and complex human diseases. [Extracted from the article]

A study conducted by the French National Institute of Health and Medical Research (INSERM) focused on pediatric acute myeloid leukemia, specifically examining the ETO2::GLIS2 fusion oncogene. The research utilized human induced pluripotent stem cells (iPSC) to model the progression of leukemia, highlighting the role of the osteogenic homeobox factor DLX3 in chromatin changes and leukemogenesis. The findings suggest that DLX3 is a crucial factor in the early stages of leukemia initiation driven by the ETO2::GLIS2 fusion oncogene. This research has been peer-reviewed and offers valuable insights into the mechanisms underlying pediatric leukemia. [Extracted from the article]

The patent issued for aryl- or heteroaryl-substituted benzene compounds by Epizyme Inc. focuses on the role of histone methyltransferases in epigenetic regulation and their potential implications in cancer treatment. The patent outlines methods for treating follicular lymphoma using specific compounds and pharmaceutically acceptable salts. This research highlights the importance of selectively modulating epigenetic enzymes for potential therapeutic applications in various diseases beyond cancer. [Extracted from the article]

A report from Case Western Reserve University discusses the role of androgens in metastatic castration-resistant prostate cancer (mCRPC) and the limitations of current treatments like enzalutamide. The study introduces AR antagonists BG-15a and BG-15n, which show promise in down-regulating AR-target genes and reducing cell and tumor growth in mCRPC models. The research suggests that these molecules disrupt chromatin clusters, offering potential as new agents for treating relapsed AR-driven mCRPC tumors. [Extracted from the article]

A patent application titled "Methods And Compositions For Characterizing Nucleic Acids Molecules In Individual Cells" was published online by the University of Washington. The application describes techniques related to GAGE-seq, a method for mapping single-cell landscapes of chromatin interactions and gene expression. This approach allows for the concurrent measurement of genome-wide 3D chromatin interactions and transcriptome in the same single cells, providing insights into cell fate decision-making during hematopoiesis and the intricate connections between genome structure and gene expression. [Extracted from the article]

The article discusses the importance of precise regulation of chromatin composition in gene expression and cellular identity, highlighting the use of the CUT&RUN method for high-resolution epigenomic profiling. The approach has been successful in various cell and tissue types, providing valuable insights into genomic distribution with high sensitivity and throughput. The article offers a detailed protocol for CUT&RUN, emphasizing best practices and controls for specific, efficient, and robust target profiling. [Extracted from the article]

The article discusses the role of histones, conserved nuclear proteins, in regulating chromatin structure and gene expression. It highlights that extracellular histones, when elevated, may contribute to various diseases. The study found that histones are secreted from cells as membrane proteins via extracellular vesicles/exosomes, with upregulation of secretion in response to cellular stress. This discovery opens avenues for further research on the biological activity of exosome-associated histones and their potential role in disease. [Extracted from the article]

Researchers from the National Cancer Institute in Bethesda, Maryland, have discovered that phosphorylation by c-Jun N-terminal kinase (JNK) triggers a functional switch in the nucleoprotein BRD4, transitioning it from a chromatin regulator to a transcriptional activator. This switch leads to the promotion of gene transcription involved in immune and inflammatory responses, as well as the induction of specific cellular processes like CD8 expression in thymocytes and epithelial-to-mesenchymal transition in prostate cancer cells. The study sheds light on the intricate mechanisms underlying BRD4's diverse functions in cellular processes and cancer development. [Extracted from the article]

A recent study conducted in Tianjin, People's Republic of China, focused on pediatric acute myeloid leukemia (pAML) and its genetic alterations affecting epigenetic states. The research utilized single-cell and clonal analysis to examine chromatin accessibility in bone marrow samples from 28 pAML patients, revealing abnormal chromatin accessibility patterns and innate immune signaling enhancements across subtypes. The findings suggest insights into disease progression, risk classification, and potential targeted therapies for pAML patients. This peer-reviewed research offers a detailed understanding of epigenetic disruption in pAML, emphasizing the importance of single-cell chromatin accessibility analysis for classification and treatment strategies. [Extracted from the article]

A recent study from the University of Wisconsin Madison explores the role of YY1-mediated PcG regulation in determining the fate of hematopoietic stem cells (HSCs). The research highlights the importance of chromatin remodeling and epigenetic mechanisms in HSC metabolism and differentiation. Disruption of YY1 PcG function may accelerate HSC aging, shedding light on innovative pathways that influence cell fate decisions in hematopoiesis. [Extracted from the article]

A new study conducted at the Technical University Munich (TUM) explores the potential mechanisms of anemia development in individuals with clonal hematopoiesis (CH). The research focuses on changes within the erythroid lineage at the hematopoietic stem cell (HSC) level, investigating alterations in cytoskeleton and chromatin condensation processes. The study reveals specific transcriptomic changes in erythroid progenitors from CH bone marrow samples, which may contribute to the development of anemia in myeloid neoplasia. The findings suggest a delayed erythroid maturation in individuals with CH compared to healthy controls, shedding light on the molecular basis of anemia in this population. [Extracted from the article]

The article discusses the role of NKX2-1 in driving neuroendocrine prostate cancer (NEPC) through epigenetic remodeling and 3D chromatin reorganization. The study found distinct chromatin architectures between NEPC and castration-resistant prostate cancer (CRPC) samples, with NKX2-1 playing a crucial role in NE transformation. The research suggests a hierarchical network of transcription factors governed by NKX2-1 in regulating chromatin reorganization during NE transformation, offering a potential therapeutic approach for NEPC treatment. [Extracted from the article]

A study conducted by the University of British Columbia in Vancouver, Canada, explores the phenotypic and clinical heterogeneity in advanced prostate cancer through plasma cell-free DNA chromatin immunoprecipitation profiling. The research highlights the importance of epigenomic features in regulating cell phenotype, providing insights into prostate cancer presentation and treatment resistance. The findings suggest that chromatin profiling of plasma cell-free DNA could serve as a valuable biomarker source and biological discovery tool for understanding aggressive prostate cancer. [Extracted from the article]

A recent study published in Nature by scientists from Gladstone Institutes and UC San Francisco explores how a protein called MED12 controls the balance between rest and activation in T cells, which are crucial for the immune system. The researchers found that MED12 plays a central role in determining when T cells rest or activate, influencing their functions. By understanding this mechanism, scientists hope to develop new therapies for diseases involving T cell dysfunction, such as cancer and autoimmune diseases. This research sheds light on the intricate orchestration of T cell responses and could lead to more effective immunotherapies in the future. [Extracted from the article]

The article explores the role of the CHD4 protein in regulating gene expression in postnatal atrial cardiomyocytes, particularly in relation to atrial fibrillation. It highlights the interaction between CHD4 and the transcription factor TBX5 in maintaining chromatin organization and gene regulatory mechanisms. The study suggests that CHD4 plays a crucial role in maintaining atrial cardiomyocyte identity and rhythm homeostasis. The findings indicate that CHD4 is essential for gene expression and identity in atrial cardiomyocytes, impacting vulnerability to atrial fibrillation. [Extracted from the article]

The research from the University of Arkansas for Medical Sciences focuses on the disease progression of multiple myeloma, a complex hematological disease characterized by abnormal plasma cell proliferation in the bone marrow. By utilizing single-nuclei multiomic technology, researchers were able to analyze gene expressions and chromatin accessible regions in different stages of the disease, from Monoclonal Gammopathy of Undetermined Significance (MGUS) to Plasma Cell Leukemia (PCL). The study highlights the importance of understanding molecular signatures and regulatory elements for early therapeutic intervention in multiple myeloma patients, shedding light on cis-regulatory interactions and regulatory domains involved in disease progression. [Extracted from the article]

Researchers from the University of California Los Angeles (UCLA) have conducted a study on the circadian control of histone turnover during cardiac development and growth. The research focused on the role of the master circadian transcription factor, Bmal1, in histone turnover, chromatin organization, and myocyte-specific gene expression in neonatal rat ventricular myocytes. The study concluded that replication-independent histone turnover is essential for transcriptional remodeling of clock-controlled genes in cardiac myocytes in response to growth stimuli. The findings provide insights into the molecular mechanisms underlying cardiac development and growth. [Extracted from the article]

Researchers at King Abdullah University of Science and Technology (KAUST) in Saudi Arabia conducted a study on disease progression in multiple myeloma (MM), a complex malignancy affecting plasma cells in the bone marrow. The study focused on the genetic and epigenetic changes that occur as the disease transitions from asymptomatic stages to active MM. By analyzing gene expression, chromatin accessibility, and histone marks, the researchers identified key regulatory elements and pathways driving MM pathogenesis, aiming to improve early screening and develop targeted therapies. The study underscores the importance of integrated multi-omics approaches in understanding the complex regulatory networks of MM. [Extracted from the article]

Researchers from Chengdu First People's Hospital conducted a study on multiple myeloma patients with normal karyotype and complex karyotype to investigate chromatin spatial structure differences. The study utilized high-throughput chromosome conformational capture analysis on plasma cells and identified significant changes in gene expression and activation of cancer-related pathways in patients with complex karyotype. This research sheds light on the impact of chromatin structure on gene expression and cancer progression in multiple myeloma patients. [Extracted from the article]

The research from Yale University explores how the linker histone regulates the myeloid versus lymphoid fate decision in multipotent hematopoietic stem and progenitor cells. The study suggests that H1.0 high HSPCs favor the lymphoid fate, potentially connecting inflammatory signals to myeloid skewing in hematopoiesis. This work provides insights into potential pharmacologic interventions to mitigate myeloid skewed hematopoiesis. For more information, the full article can be accessed for free at https://doi.org/10.1182/blood-2024-211935. [Extracted from the article]

A study conducted at the Kusuma School of Biological Science in New Delhi, India, focused on the mechanism of thalidomide therapy-related B cell acute lymphoblastic leukemia (B-ALL). The research revealed that thalidomide treatment of B cell lines increased CD34 expression and fibronectin adhesion, resembling the effects of Ikzf1 loss of function mutations in B-ALL. The study concluded that thalidomide alters the chromatin occupancy of IKZF1 at key B-cell lineage transcription factors, leading to a persistent block in B-cell differentiation. [Extracted from the article]

A recent study conducted by researchers at Central South University in China focused on Richter's syndrome, a severe progression of chronic lymphocytic leukemia into aggressive lymphoma. The study utilized single-cell RNA sequencing and high-throughput chromosome conformation capture sequencing to analyze a patient with CLL that transformed into DLBCL. The findings revealed dynamic genome architecture reorganization during differentiation and neoplastic transformation, affecting cAMP-mediated signaling pathways. This research sheds light on the molecular basis of Richter's syndrome and highlights the importance of further investigation into cAMP signaling in this context. [Extracted from the article]

The article discusses how colorectal cancer cells can adapt to replication stress by activating new replication origins, leading to changes in chromatin dynamics, nuclear morphology, and gene expression. This adaptation allows cancer cells to maintain proliferation under stress and may contribute to tumor heterogeneity. The research suggests that targeting replication origin activation could be a potential therapeutic strategy to combat cancer cell resilience. The preprint has not yet undergone peer review. [Extracted from the article]

Researchers from Amsterdam University Medical Center conducted a Phase 1 trial on CD22-directed CAR T cell therapy for patients with relapsed/refractory large B cell lymphoma. The study of 38 patients showed an overall objective response rate of 68% and a complete response rate of 53%. The research identified features in CAR22 products and expanding CAR22 cells associated with immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome (IEC-HS), providing insights into the transcriptional and epigenetic mechanisms underlying the syndrome. The findings suggest potential biomarkers for increased risk of IEC-HS and avenues for early detection and targeted intervention to improve the safety of CAR T cell therapies. [Extracted from the article]

The article discusses a novel method called LIONHEART for cancer detection using cell-free DNA fragment coverage and open chromatin sites across different cell types. The method aims to overcome systematic biases and generalize across datasets to detect changes in cell-free DNA composition caused by cancer. Testing on multiple datasets and cancer types showed promising results in distinguishing cancer samples from non-cancer controls, with a mean ROC AUC score of 0.80. The preprint has not been peer-reviewed, and more information can be found at medrxiv.org/content/10.1101/2024.11.26.24317971v1. [Extracted from the article]